Review Article

Machine Learning: Applications and Advanced Progresses of Radiomics in Endocrine Neoplasms

Table 5

Different clinical applications of radiomic models (features) in prostate cancer.

ReferencesCase numbersRadiomic methodResults

[147]206MRIThe phenotype of clinically significant peripheral zone PCa lesions could be predicted by using radiomic features
[148]381MRIRadiomic prediction model had an improved diagnostic ability when compared with the clinical model
[149]117MRIRadiomic model was adaptive to detect dominant intraprostatic lesions in patients with PCa
[150]30MRIQuantitative radiomic features based on MRI radiomics could be utilized to predict the localization of PCa
[151]50USQuantitative radiomic features based on US radiomics could be utilized to predict the localization of PCa
[144]381MRIMRI-based radiomic models had a reliable ability to distinguish PCa with non-PCa patients as well as assess the tumor aggressiveness
[153]73MRIRadiomic features had the potential to predict risk stratification of PCa
[156]23MRIThe focal treatment plans formed by using the framework were decreased in dosage to the organs at risk and a boosted dose delivered to the cancerous lesions
[158]62MRIRadiomic features had good classification performance for Gleason score of patients in PCa
[159]71MRIRadiomic features had the potential to predict the prognosis of PCa
[160]107MRIRadiomic features were predictive of biochemical recurrence after prostatectomy in PCa
[161]120MRIRadiomic features can be predictive of PCa BCR and may help identify men who would benefit from adjuvant therapy
[162]91MRIMRI-based radiomics could predict BCR of localized PCa after radiation therapy
[163]195MRIMRI-based radiomic models had the potential to predict BCR of high-risk PCa